| H20020010 | 拉莫三嗪片 | lamotrigine | Tablet | Chemical Drugs | Import Drug Application | 2002-02-26 | 葛兰素史克（中国）投资有限公司北京办事处 | Glaxosmithkline China Beijing | Approval Completed-Pending Certificated | | view |
| H20020286 | 阿昔洛韦软膏 | aciclovir | Ointment | Chemical Drugs | Import Drug Application | 2002-11-22 | 葛兰素史克（中国）投资有限公司北京办事处 | Glaxosmithkline China Beijing | Approval Completed-Pending Certificated | | view |
| JXHL1400159 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Import Drug Application | 2014-05-22 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2015-03-04 | view |
| JYHB2001269 | 乌美溴铵维兰特罗吸入粉雾剂 | umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2020-08-06 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | Filed | 2020-08-19 | view |
| J0200136 | 顺苯磺阿曲库铵注射液 | cisatracurium besilate | Injection | Chemical Drugs | License Renew | 2004-03-09 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2004-07-08 | view |
| JYHB1501385 | 阿莫西林钠克拉维酸钾 | amoxicillin sodium;potassium clavulanate | Active ingredient | Chemical Drugs | Supplementary Application | 2015-10-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd | Certificate Issued | 2016-09-07 | view |
| JYHB2002745 | 硫酸阿巴卡韦片 | abacavir sulfate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;GlaxoSmithKline Phaemaceuticals SA | Certificate Issued | 2021-02-01 | view |
| JYHB1700495 | 扎那米韦吸入粉雾剂 | zanamivir | Powder for inhalation | Chemical Drugs | Supplementary Application | 2017-05-13 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd | In Review | 2017-05-10 | view |
| JYHB0900901 | 羟萘酸沙美特罗吸入粉雾剂 | Salmeterol Hydroxynaphthoate | Powder for inhalation | Chemical Drugs | Supplementary Application | 2009-10-13 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome Production;Glaxo Wellcome Operations | Certificate Issued | 2010-10-19 | view |
| JYSB1200228 | 流感病毒裂解疫苗 | influenza vaccine(split virion),inactivated | Injection | Biological Products | Supplementary Application | 2012-10-10 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxosmithkline Biologicals Branch Of Smithkline Beecham Pharma Gmbh & Co KG | Certificate Issued | 2013-10-23 | view |
| JXHS1800060 | 乌美溴铵吸入粉雾剂 | umeclidinium bromide | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2018-11-30 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | Certificate Issued | 2020-01-02 | view |
| JXHS1200065 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Import Drug Application | 2012-06-28 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd | Certificate Issued | 2014-03-06 | view |
| H20020195 | 盐酸雷尼替丁片 | ranitidine hydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2002-08-07 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2002-12-16 | view |
| JYHB1400321 | 注射用头孢他啶 | ceftazidime | Lyophilized | Chemical Drugs | Supplementary Application | 2014-03-27 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Manufacturing SpA;GlaxoSmithKjine SpA | Certificate Issued | 2014-11-02 | view |
| JXHL2000170 | GSK3228836 注射液 | bepirovirsen | Injection | Chemical Drugs(1) | Import Drug Application | 2020-07-06 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxosmithkline Trading Services Ltd | In Review | 2020-07-04 | view |
| JXHS1500037 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Import Drug Application | 2015-04-24 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2016-01-11 | view |
| JYSB2000587 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-11-30 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Filed | 2020-12-16 | view |
| JYHB1601435 | 沙美特罗替卡松粉吸入剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2016-11-16 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2017-06-09 | view |
| JYSB2100054 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | In Review | 2021-02-22 | view |
| JYSB1800066 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2018-04-13 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Filed | 2018-04-27 | view |
